Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwNHL 2014 | Managing patients with non-Hodgkin lymphoma

Steven Rosen • 5 Sep 2014
iwNHL 2014
Non-Hodgkin Lymphoma

At the iwNHL 2014, Dr Steven Rosen (City of Hope National Medical Center, California, USA) describes the progress made in understanding the biology and management of non-Hodgkin lymphoma. Now, there is need to consider new drug combinations to maximize efficacy. Alternatives to chemotherapy including biologic approaches and future research directions including in precision medicine are examined.

More from Steven Rosen

2:03
The challenging field of hem-onc therapeutics
Steven Rosen • 21 Sep 2018
1:09
Non-hodgkin lymphoma advances in 2018
Steven Rosen • 21 Sep 2018
1:33
CAR T-cell therapy: on the way to success
Steven Rosen • 21 Sep 2018
1:22
Update on CAR T-cell therapy at the City of Hope
Steven Rosen • 27 Sep 2018

Related Videos

3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
1:48
Novel immunotherapy approaches in lymphoma: CAR-T cells, bispecifics & sequencing
Gloria Iacoboni • 15 Apr 2024
2:09
Using lineage tracing to define responding CAR T-cells in patients with LBCL
Zinaida Good • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals